Galaxy Biotech LLC is developing humanized antibodies against growth factors and their receptors for the treatment of cancer. The company was founded by Dr. Jin Kim, who while a senior scientist at Genentech, Inc. developed the mouse mAb from which the approved drug Avastin(R) was made, and by Dr. Cary Queen, who previously co-founded PDL BioPharma, Inc. and developed fundamental technology for the humanization of antibodies.
